Clovis Oncology
(NASDAQ:CLVS)
0.69
0.0158[2.34%]
At close: May 27
0.6999
0.0099[1.43%]
After Hours: 7:00PM EDT
Day High/Low0.62 - 0.72
52 Week High/Low0.61 - 7.24
Open / Close0.72 / 0.69
Float / Outstanding141.1M / 143.9M
Vol / Avg.4.5M / 11.8M
Mkt Cap99.3M
P/E-
50d Avg. Price1.67
Div / Yield-
Payout Ratio-
EPS-0.44
Total Float141.1M

Clovis Oncology (NASDAQ:CLVS), Quotes and News Summary

Clovis Oncology (NASDAQ: CLVS)

Day High/Low0.62 - 0.72
52 Week High/Low0.61 - 7.24
Open / Close0.72 / 0.69
Float / Outstanding141.1M / 143.9M
Vol / Avg.4.5M / 11.8M
Mkt Cap99.3M
P/E-
50d Avg. Price1.67
Div / Yield-
Payout Ratio-
EPS-0.44
Total Float141.1M
Benzinga - May 9, 2022, 6:27AM
Benzinga - Mar 31, 2022, 9:05AM
load more
Sector: Health Care.Industry: Biotechnology
Clovis Oncology Inc is a biopharmaceutical company. It is focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, the EU, and additional international markets. The firm targets its development programs for the treatment of specific subsets of cancer populations. Its product candidates include Rucaparib and Lucitanib. Rucaparib is an oral small molecule inhibitor of poly ADP-ribose polymerase, is marketed in the United States for two indications specific to the recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer whereas Lucitanib includes Rucaparib Combo and Nivolumab Combo.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-03
REV
Q1 2022Est.ActualSurprise
EPS-0.430-0.440 -0.0100
REV36.970M34.247M-2.723M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Clovis Oncology Questions & Answers

Q
How do I buy Clovis Oncology (CLVS) stock?
A

You can purchase shares of Clovis Oncology (NASDAQ: CLVS) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Clovis Oncology's (CLVS) competitors?
Q
What is the target price for Clovis Oncology (CLVS) stock?
A

The latest price target for Clovis Oncology (NASDAQ: CLVS) was reported by HC Wainwright & Co. on Friday, May 6, 2022. The analyst firm set a price target for 0.00 expecting CLVS to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Clovis Oncology (CLVS)?
A

The stock price for Clovis Oncology (NASDAQ: CLVS) is $0.69 last updated May 27, 2022, 8:00 PM UTC.

Q
Does Clovis Oncology (CLVS) pay a dividend?
A

There are no upcoming dividends for Clovis Oncology.

Q
When is Clovis Oncology (NASDAQ:CLVS) reporting earnings?
A

Clovis Oncology’s Q2 earnings are confirmed for Wednesday, August 3, 2022.

Q
Is Clovis Oncology (CLVS) going to split?
A

There is no upcoming split for Clovis Oncology.

Q
What sector and industry does Clovis Oncology (CLVS) operate in?
A

Clovis Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.